搜尋結果
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 2 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Martinez demands focus as Portugal brace for Turkish storm
Reuters· 3 小時前Turkey's fans are set to create a raucous atmosphere again as their team face Portugal at ...
Ron Insana: Never mind the narrow leadership. This is a powerful bull market
CNBC· 3 小時前There has been a fair amount of nervous chatter lately about the state of the stock market. ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 3 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Wall St Week Ahead Rally in U.S. big tech stocks may be getting stretched
Reuters· 3 小時前A blistering rally in U.S. big tech stocks may be due for a breather, offering hope for market ...
Dot's AI really, really wants to get to know you
TechCrunch· 3 小時前Or, if you’re struggling in some area like the fallout from a career change, as Dot’s ...
These are the 10 best cities for new college graduates—New York City didn't make the list
CNBC· 4 小時前Zumper ranked 100 cities based on median rent prices, average income, unemployment rate, and ...
Apple to delay launch of AI-powered features in Europe, blames EU tech rules
Reuters· 4 小時前, opens new tab will delay launching three new artificial intelligence features because ...
S&P 500 to break above 5,700 in the second half of 2024, Ned Davis Research says
CNBC· 6 小時前Historical post-election market gains could lead the S & P 500 even higher by the end of the ...
$2 billion Baltimore bridge rebuild is test case for new national debate over infrastructure ...
CNBC· 11 小時前In an aerial view, the remains of the Francis Scott Key Bridge are seen as salvage crews ...